Skip to main content
NCBI home page
Infection and Immunity logoLink to Infection and Immunity
. 1990 Mar;58(3):680–686. doi: 10.1128/iai.58.3.680-686.1990

Polyclonal anti-idiotypic antibodies exhibit antigenic mimicry of limited type 1 fimbrial proteins of Escherichia coli.

R E Paque 1, R Miller 1, V Thomas 1
PMCID: PMC258519  PMID: 1968431

Abstract

Polyclonal anti-idiotypic antibodies (anti-Ids)(fim) developed against idiotypes on antibodies (Ab-1s) that specifically bind structural, organelle fimbrial proteins of Escherichia coli were able to modulate immune function in anti-Id(fim)-immunized mice. Proliferation or suppression of splenic lymphoid cell responses by polyclonal anti-Ids in tissue culture appeared to be dose dependent. Anti-Ids were able to induce a dose-dependent T-cell-mediated immunity specific for type 1 fimbrial antigen(s) in immunized animals when assessed in vitro, but they failed to elicit in vivo positive ear-swelling skin reactions. Anti-Ids were unable to induce protective immunity against an in vivo infectious challenge with E. coli in anti-Id-immunized adult animals, but they stimulated a specific, secondary antibody response in anti-Id-challenged mice. Anti-Ids stimulated the development of anti-anti-Ids (Ab-3s) specifically binding a fimbrial antigen(s) and revealed the presence of antibody idiotypes binding E. coli adhesin proteins in the 27- to 29-kilodalton range. Results suggest discrete, but subtle, immunomodulatory effects of the anti-Ids and potential vaccinoid properties capable of stimulating a specific humoral and cellular response in vivo.

Full text

PDF
680

Images in this article

682Image
on p.682

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abraham S. N., Beachey E. H. Assembly of a chemically synthesized peptide of Escherichia coli type 1 fimbriae into fimbria-like antigenic structures. J Bacteriol. 1987 Jun;169(6):2460–2465. doi: 10.1128/jb.169.6.2460-2465.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Abraham S. N., Goguen J. D., Beachey E. H. Hyperadhesive mutant of type 1-fimbriated Escherichia coli associated with formation of FimH organelles (fimbriosomes). Infect Immun. 1988 May;56(5):1023–1029. doi: 10.1128/iai.56.5.1023-1029.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Abraham S. N., Goguen J. D., Sun D., Klemm P., Beachey E. H. Identification of two ancillary subunits of Escherichia coli type 1 fimbriae by using antibodies against synthetic oligopeptides of fim gene products. J Bacteriol. 1987 Dec;169(12):5530–5536. doi: 10.1128/jb.169.12.5530-5536.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Baker P. J., Morse H. C., 3rd, Cross S. S., Stashak P. W., Prescott B. Maturation of regulatory factors influencing magnitude of antibody response to capsular polysaccharide of type III Streptococcus pneumoniae. J Infect Dis. 1977 Aug;136 (Suppl):S20–S24. doi: 10.1093/infdis/136.supplement.s20. [DOI] [PubMed] [Google Scholar]
  5. Bona C., Hooghe R., Cazenave P. A., Leguérn C., Paul W. E. Cellular basis of regulation of expression of idiotype. II. Immunity to anti-MOPC-460 idiotype antibodies increases the level of anti-trinitrophenyl antibodies bearing 460 idiotypes. J Exp Med. 1979 Apr 1;149(4):815–823. doi: 10.1084/jem.149.4.815. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Cosenza H., Köhler H. Specific suppression of the antibody response by antibodies to receptors. Proc Natl Acad Sci U S A. 1972 Sep;69(9):2701–2705. doi: 10.1073/pnas.69.9.2701. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Dodd D. C., Eisenstein B. I. Antigenic quantitation of type 1 fimbriae on the surface of Escherichia coli cells by an enzyme-linked immunosorbent inhibition assay. Infect Immun. 1982 Nov;38(2):764–773. doi: 10.1128/iai.38.2.764-773.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Fujinami R. S., Oldstone M. B. Molecular mimicry as a mechanism for virus-induced autoimmunity. Immunol Res. 1989;8(1):3–15. doi: 10.1007/BF02918552. [DOI] [PubMed] [Google Scholar]
  9. Gander R. M., Thomas V. L. Distribution of type 1 and P pili on uropathogenic Escherichia coli O6. Infect Immun. 1987 Feb;55(2):293–297. doi: 10.1128/iai.55.2.293-297.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Hiernaux J., Bona C., Baker P. J. Neonatal treatment with low doses of anti-idiotypic antibody leads to the expression of a silent clone. J Exp Med. 1981 Apr 1;153(4):1004–1008. doi: 10.1084/jem.153.4.1004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Jerne N. K., Roland J., Cazenave P. A. Recurrent idiotopes and internal images. EMBO J. 1982;1(2):243–247. doi: 10.1002/j.1460-2075.1982.tb01154.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Jerne N. K. Towards a network theory of the immune system. Ann Immunol (Paris) 1974 Jan;125C(1-2):373–389. [PubMed] [Google Scholar]
  13. Kaijser B., Ahlstedt S. Protective capacity of antibodies against Escherichia coli and K antigens. Infect Immun. 1977 Aug;17(2):286–289. doi: 10.1128/iai.17.2.286-289.1977. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Kennedy R. C., Dreesman G. R. Common idiotypic determinant associated with human antibodies to hepatitis B surface antigen. J Immunol. 1983 Jan;130(1):385–389. [PubMed] [Google Scholar]
  15. Kennedy R. C., Melnick J. L., Dreesman G. R. Antibody to hepatitis B virus induced by injecting antibodies to the idiotype. Science. 1984 Mar 2;223(4639):930–931. doi: 10.1126/science.6198721. [DOI] [PubMed] [Google Scholar]
  16. McNamara M. K., Ward R. E., Kohler H. Monoclonal idiotope vaccine against Streptococcus pneumoniae infection. Science. 1984 Dec 14;226(4680):1325–1326. doi: 10.1126/science.6505692. [DOI] [PubMed] [Google Scholar]
  17. Paque R. E., Miller R. Modulation of murine coxsackievirus-induced myocarditis utilizing anti-idiotypes. Viral Immunol. 1987;1(3):207–224. doi: 10.1089/vim.1987.1.207. [DOI] [PubMed] [Google Scholar]
  18. Paque R. E., Miller R. Monoclonal anti-idiotypic antibodies regulate the expression of virus-induced murine myocarditis. Infect Immun. 1989 Sep;57(9):2864–2871. doi: 10.1128/iai.57.9.2864-2871.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Paque R. E., Miller R. Polyclonal anti-idiotypes influence macrophage chemotaxis in coxsackievirus-induced murine myocarditis. J Leukoc Biol. 1989 Jan;45(1):79–86. doi: 10.1002/jlb.45.1.79. [DOI] [PubMed] [Google Scholar]
  20. Rodkey L. S. Autoregulation of immune responses via idiotype network interactions. Microbiol Rev. 1980 Dec;44(4):631–659. doi: 10.1128/mr.44.4.631-659.1980. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Rubinstein L. J., Goldberg B., Hiernaux J., Stein K. E., Bona C. A. Idiotype-antiidiotype regulation. V. The requirement for immunization with antigen or monoclonal antiidiotypic antibodies for the activation of beta 2 leads to 6 and beta 2 leads to 1 polyfructosan-reactive clones in BALB/c mice treated at birth with minute amounts of anti-A48 idiotype antibodies. J Exp Med. 1983 Oct 1;158(4):1129–1144. doi: 10.1084/jem.158.4.1129. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Rubinstein L. J., Yeh M., Bona C. A. Idiotype-anti-idiotype network. II. Activation of silent clones by treatment at birth with idiotypes is associated with the expansion of idiotype-specific helper T cells. J Exp Med. 1982 Aug 1;156(2):506–521. doi: 10.1084/jem.156.2.506. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Sacks D. L., Esser K. M., Sher A. Immunization of mice against African trypanosomiasis using anti-idiotypic antibodies. J Exp Med. 1982 Apr 1;155(4):1108–1119. doi: 10.1084/jem.155.4.1108. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Sacks D. L., Sher A. Evidence that anti-idiotype induced immunity to experimental African trypanosomiasis is genetically restricted and requires recognition of combining site-related idiotopes. J Immunol. 1983 Sep;131(3):1511–1515. [PubMed] [Google Scholar]
  25. Stein K. E., Söderström T. Neonatal administration of idiotype or antiidiotype primes for protection against Escherichia coli K13 infection in mice. J Exp Med. 1984 Oct 1;160(4):1001–1011. doi: 10.1084/jem.160.4.1001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Ward M. M., Ward R. E., Huang J. H., Kohler H. Idiotope vaccine against Streptococcus pneumoniae. A precursor study. J Immunol. 1987 Oct 15;139(8):2775–2780. [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES